Vyome Holdings (HIND) Debt Ratio (2015 - 2025)
Vyome Holdings (HIND) posted quarterly Debt Ratio of 0.45 for Q2 2025, down 15.39% year-over-year from 0.53 in Q2 2024, and down 82.78% quarter-over-quarter from 2.6 in Q4 2024.
Vyome Holdings (HIND) Debt Ratio (2015 - 2025) Analysis & Trends
Vyome Holdings' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.45 for Q2 2025.
- In Q2 2025, Debt Ratio fell 15.39% year-over-year to 0.45; the TTM figure through Jun 2025 stood at 0.45 (down 15.39% YoY), while the FY2024 annual figure was 2.6, up 845.22% from the prior year.
- Debt Ratio for Q2 2025 stood at 0.45, down from 2.6 in the prior quarter.
- The five-year high for Debt Ratio was 2.6 in Q4 2024, with the low at 0.02 in Q1 2021.
- The 4-year median for Debt Ratio is 0.27 (2023), against an average of 0.57.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio soared 845.22% in 2024, then fell 15.39% in 2025.
- Vyome Holdings' Debt Ratio stood at 0.07 in 2021, then jumped by 317.94% to 0.27 in 2023, then jumped by 845.22% to 2.6 in 2024, then slumped by 82.78% to 0.45 in 2025.
- Business Quant data shows HIND's Debt Ratio at 0.45 in Q2 2025, 2.6 in Q4 2024, and 0.53 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.45 |
| Dec 31, 2024 | 2.60 |
| Jun 30, 2024 | 0.53 |
| Dec 31, 2023 | 0.27 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.02 |
| Dec 31, 2020 | 0.34 |
| Sep 30, 2020 | 0.04 |
| Jun 30, 2020 | 0.03 |
| Jun 30, 2019 | 0.52 |
| Mar 31, 2019 | 1.23 |
| Dec 31, 2018 | 0.65 |
| Sep 30, 2018 | 0.28 |
| Jun 30, 2018 | 0.43 |
| Mar 31, 2018 | 0.25 |
| Dec 31, 2017 | 0.19 |
| Sep 30, 2017 | 0.17 |
| Jun 30, 2017 | 0.15 |
| Mar 31, 2017 | 0.14 |